Apollo Capital Management, L.P. / Apollo Funds
McKesson closes Apollo Funds investment in Medical-Surgical Solutions
Summary: McKesson announced that it completed the previously announced minority ownership interest investment from funds managed by affiliates of Apollo in McKesson Medical-Surgical Solutions on June 1, 2026. The announcement says Apollo Funds invested $1.25 billion in convertible preferred equity for an approximately 13% interest, while McKesson retained operating control and majority ownership.
Why it matters: The update may matter to due-diligence readers as a public Apollo private-capital activity signal in healthcare distribution and corporate carve-out/separation planning.
Summary
McKesson announced that it completed the previously announced minority ownership interest investment from funds managed by affiliates of Apollo in McKesson Medical-Surgical Solutions on June 1, 2026. According to McKesson, Apollo Funds invested $1.25 billion in convertible preferred equity for an approximately 13% interest, while McKesson retained operating control and majority ownership.
This item treats McKesson as the primary issuer source for the closing, economics, and ownership-control details. IPO, separation, growth, valuation, and strategic-rationale language should remain attributed to McKesson rather than presented as independent validation by 9AT.
Why it matters
For due-diligence readers, the closing is relevant as a public signal of Apollo-affiliated funds providing structured minority capital to a healthcare distribution business while the issuer remains in operational control. The update may be useful for watching Apollo’s private-capital activity around corporate carve-outs, preferred-equity structures, healthcare services, and sponsor/issuer governance boundaries.
The announcement does not support any conclusion about Apollo fund performance, the future value of McKesson Medical-Surgical Solutions, the likelihood or timing of a separation or IPO, or whether the transaction is attractive for investors. It should not be read as advice about McKesson, Apollo, any Apollo-managed fund, or any security.
Source notes
- McKesson announcement: https://www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-closes-strategic-investment-with-apollo-funds-for-minority-interest-in-medical-surgical-solutions/
- Source posture: primary issuer/company announcement.
- Source support: the McKesson announcement supports the June 1, 2026 closing, Apollo Funds’ $1.25 billion convertible preferred equity investment, the approximately 13% minority interest, and McKesson’s retained operating control and majority ownership.
- Editorial caveat: distinguish this June closing from the earlier April agreement. Attribute transaction economics and separation/IPO/growth framing to McKesson, and do not infer fund-level exposure or performance.
9AT filing context
Public ADV/profile context maps the target lane to Apollo Capital Management, L.P. in New York, with CRD 143161, SEC file 801-67592, and public website/domain apollo.com. Public profile context used in review reports about $751.8 billion in reported regulatory AUM/profile scale, 10,692 employees, 2,736 advisory employees, 786 private funds, SMA flag true, ERA flag false, and a 2026-04-28 ADV submission.
That context is broad Apollo platform background only. It helps identify the adviser/platform lane, but it does not validate the closing, valuation, separation plan, healthcare strategy, fund-level exposure, preferred-equity terms, or future operating results.
The available 13F filing-history lookup for the matched Apollo profile returned no filer. Even if a separate public 13F mapping were later documented, 13F would generally not be central to this private/minority-interest transaction, so this item omits 13F context.
What to watch
Watch for McKesson, Apollo, rating-agency, regulatory, or future transaction materials that clarify governance rights, separation timing, operating-control changes, use of proceeds, preferred-equity terms, and any additional public disclosures about how Medical-Surgical Solutions is capitalized or positioned after the minority investment.